Skip to main content
Clinical Trials/NL-OMON23211
NL-OMON23211
Completed
Not Applicable

Prevention of recurrent urinary tract infections by multi-drug resistant bacteria, by intravesical administration of gentamicin.

eiden University Medical Center0 sites170 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
recurrent urinary tract infectionsmulti-drug resistant bacteriacystitisprophylaxisrecidiverende urineweginfectiesmulti resistente bacterieen
Sponsor
eiden University Medical Center
Enrollment
170
Status
Completed
Last Updated
last year

Overview

Brief Summary

van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. Int J Antimicrob Agents. 2010 Dec;36(6):485-90

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Competent patient aged 18 or above.
  • \- A history of recurrent cystitis, defined as:

Exclusion Criteria

  • \- Urinary culture in prior 6 months tested positive for high\-level gentamicin resistant enterobacteriaceae or enterococci (MIC \>128 mg/L).
  • \- Abnormalities of the upper urinary tract, including presence of urinary stones.

Outcomes

Primary Outcomes

Not specified

Similar Trials